RETRACTED: Exploring the applications of formulation-based drug development strategies in neurological disorders using artificial intelligence and machine learning approaches [PDF]
Ashok Aspatwar +3 more
openalex +1 more source
Chronological and Spatial Distribution of Skeletal Muscle Fat Replacement in FHL1‐Related Myopathies
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objectives Variants in the FHL1 gene cause FHL1‐related myopathies (FHL1‐RMs), a group of neuromuscular disorders with diverse clinical presentations. This study aimed to comprehensively characterize the spatial and temporal patterns of skeletal muscle fat replacement throughout the whole body in FHL1‐RMs, to examine disease progression over ...
Rui Shimazaki +8 more
wiley +1 more source
Use of Symptomatic Drug Treatment for Fatigue in Multiple Sclerosis and Patterns of Work Loss
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective To describe the use of central stimulants and amantadine for fatigue in MS and evaluate a potential association with reduced work loss in people with MS. Methods We conducted a nationwide, matched, register‐based cohort study in Sweden (2006 to 2023) using national registers with prospective data collection.
Simon Englund +3 more
wiley +1 more source
Unmasking cerebellar disease: functional neurologic disorder as a precursor to spinocerebellar ataxia type 8 [PDF]
Sopiko Jimsheleishvili +2 more
openalex +1 more source
A common data language for clinical research studies: the National Institute of Neurological Disorders and Stroke and American Academy for Cerebral Palsy and Developmental Medicine Cerebral Palsy Common Data Elements Version 1.0 recommendations [PDF]
, 2018 Verónica Schiariti +12 more
openalex +1 more source
A novel IRF2BPL gene mutation manifesting as a broad spectrum of neurological disorders: a case report [PDF]
, 2023 W Khan, Hamza Maqsood, Shifa Younus
openalex +1 more source
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective This study aimed to systematically observe the clinical manifestations, immune cell subsets, and dynamic changes in serological indicators in patients with myasthenia gravis (MG) before and after efgartigimod (EFG) treatment. Methods We analyzed the baseline data, laboratory parameters, and lymphocyte subset proportions in MG ...
Tiancheng Luo +9 more
wiley +1 more source
In vivo diagnosis of TDP-43 proteinopathies: in search of biomarkers of clinical use
Translational NeurodegenerationTDP-43 proteinopathies are a heterogeneous group of neurodegenerative disorders that share the presence of aberrant, misfolded and mislocalized deposits of the protein TDP-43, as in the case of amyotrophic lateral sclerosis and some, but not all ...
Juan I. López-Carbonero +6 more
doaj +1 more source
Disparities in Genetic Testing for Neurologic Disorders [PDF]
Aaron Baldwin +20 more
openalex +1 more source